Skip to main content
Fig. 2 | BMC Medical Genomics

Fig. 2

From: Bioinformatics prediction of miR-30a targets and its inhibition of cell proliferation of osteosarcoma by up-regulating the expression of PTEN

Fig. 2

miR-30a mimic and miR-30a inhibitor is used to change the endogenous level of miR-30a. a The osteosarcoma cells MG63 were plated into a 48-well plate and transfected with miR-30a inhibitor and inhibitor negative control for 24 h. The relative level of miR-30a was determined by real-time PCR assay. **p < 0.01, compared with inhibitor control transfected group. b MG63 cells were transfected with miR-30a mimic and mimic control for 24 h and the relative level of miR-30a was determined by real time PCR assay. The relative level of miR-30a in miR-30 mimic transfected group and mimic negative control group had a significant difference (**p < 0.01)

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us